Magnetic Resonance Imaging (MRI) of Intratumoral Voxel Heterogeneity as a Potential Response Biomarker: Assessment in a HER2+ Esophageal Adenocarcinoma Xenograft Following Trastuzumab and/or Cisplatin Therapy()()

We evaluated magnetic resonance imaging (MRI) voxel heterogeneity following trastuzumab and/or cisplatin in a HER2+ esophageal xenograft (OE19) as a potential response biomarker. OE19 xenografts treated with saline (controls), monotherapy, or combined cisplatin and trastuzumab underwent 9.4-T MRI. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Yip, Connie, Weeks, Amanda, Shaw, Karen, Siddique, Musib, Chang, Fuju, Landau, David B., Cook, Gary JR., Goh, Vicky
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2017
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408154/
https://www.ncbi.nlm.nih.gov/pubmed/28456115
http://dx.doi.org/10.1016/j.tranon.2017.03.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408154/
https://www.ncbi.nlm.nih.gov/pubmed/28456115
http://dx.doi.org/10.1016/j.tranon.2017.03.006

Ejemplares similares